Search results for "Perte"

showing 10 items of 1643 documents

New Obesity Indices and Adipokines in Normotensive Patients and Patients With Hypertension

2013

We compared the obesity parameters and selected adipokines—leptin, adiponectin, and resistin—in obese patients with hypertension and normotensive patients. A total of 67 nondiabetic obese outpatients were divided into 2 groups: A–hypertensive and B–normotensive. Serum levels of leptin, adiponectin, resistin, and insulin were measured. Weight, height, waist circumference, and hip circumference were measured to calculate waist-to-hip ratio (WHR), weight-to-height ratio, visceral adiposity index, and body adiposity index (BAI). Among patients with hypertension, significant positive correlations were observed between leptin and body mass index and BAI ( r = .31 and r = .63, respectively). In n…

AdultLeptinMalemedicine.medical_specialtyAdipokinePilot ProjectsIntra-Abdominal FatBody adiposity indexBody Mass IndexWaist–hip ratioPredictive Value of TestsInternal medicineobesity hypertension adipokines obesity indicesHumansMedicineResistinObesityAdiposityAdiponectinWaist-Hip Ratiobusiness.industryLeptinnutritional and metabolic diseasesMiddle Agedmedicine.diseaseObesityEndocrinologyCase-Control StudiesHypertensionFemaleResistinAdiponectinWaist CircumferenceCardiology and Cardiovascular MedicinebusinessBody mass indexBiomarkershormones hormone substitutes and hormone antagonistsAngiology
researchProduct

Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated…

2013

To evaluate the accuracy of liver transient elastography (TE), spleen TE and other noninvasive tests (AAR, APRI score, platelet count, platelet/spleen ratio) in predicting the presence and the size of oesophageal varices in compensated hepatitis C virus (HCV) cirrhosis, we studied 112 consecutive patients with compensated HCV cirrhosis who underwent biochemical tests, gastrointestinal endoscopy, liver TE and spleen TE by Fibroscan(®) (Echosens, Paris, France) using a modified software version with a range between 1.5 and 150 kPa. Spleen TE was not reliable in 16 patients (14.3%). Among the 96 patients with a valid measurement (69.8% men, mean age: 63.2 ± 9.5 years), 43.7% had no oesophageal…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisHepatitis C virusSpleenmedicine.disease_causeEsophageal and Gastric VaricesGastroenterologySensitivity and SpecificityVaricose VeinsVirologyInternal medicinemedicineHumansProspective StudiesAgedUnivariate analysisHepatologybusiness.industrycirrhosisHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseFibrosisInfectious Diseasesmedicine.anatomical_structureROC CurvePortal hypertensionElasticity Imaging TechniquesFemaleVaricesTransient elastographybusinessBiomarkersSpleen
researchProduct

Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis

2011

Background and aims Portal vein thrombosis (PVT) negatively impacts the prognosis in patients with cirrhosis. The aim of our study was to evaluate the effects of transjugular intrahepatic portosystemic shunt (TIPS) placement in patients with cirrhosis complicated by PVT. Methods Seventy consecutive cirrhotic patients with non-tumoural PVT treated with TIPS for portal hypertension complications from January 2003 to February 2010 in a tertiary-care centre were followed until last clinical evaluation, liver transplantation, or death. Results TIPS was successfully placed without major procedure-related complications. After TIPS, the portal venous system was completely recanalised in 57% of pati…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisvenous thrombosimedicine.medical_treatmentSettore MED/50 - Scienze Tecniche Mediche ApplicatePortal venous systemLiver transplantationmeta-analysiSettore MED/01 - Statistica MedicaSpontaneous bacterial peritonitistransjugular intrahepatic portosystemic shuntmedicineHumansAgedVenous ThrombosisPortal Veinbusiness.industryGastroenterologyMiddle Agedmedicine.diseaseLiver TransplantationPortal vein thrombosisSurgeryVenous thrombosisrisk-factorTreatment OutcomeLiver-transplantationPortal hypertensionFemaleRadiologyPortasystemic Shunt Transjugular IntrahepaticEpidemiologic MethodsTomography X-Ray ComputedbusinessTransjugular intrahepatic portosystemic shuntLiver Circulation
researchProduct

Congenital hepatic fibrosis: CT findings in 18 adults.

2004

To evaluate the computed tomographic (CT) findings in adult patients with pathologically proved congenital hepatic fibrosis.This was a retrospective review of congenital hepatic fibrosis cases identified at two institutions over the course of 8 years. Eight men and 10 women with an age range of 22-72 years (mean age, 39 years) were included. Contrast material-enhanced and unenhanced CT scans were obtained through the liver in all patients. Two radiologists evaluated size of and morphologic findings (atrophy or hypertrophy localized according to hepatic segments) in the liver; increased diameter or number of hepatic arteries at the hilum; presence of hepatic nodules, varices, spontaneous spl…

AdultLiver CirrhosisMalemedicine.medical_specialtyCommon Bile Duct Diseasesmedicine.medical_treatmentSplenectomyHilum (biology)Hepatic VeinsKidneyGastroenterologyHepatic ArteryAtrophyFibrosisInternal medicineHypertension PortalHumansMedicineRadiology Nuclear Medicine and imagingAgedRetrospective StudiesPortal Veinbusiness.industryHypertrophyMiddle Agedmedicine.diseaseDuctal Plate MalformationLiverPortal hypertensionCongenital hepatic fibrosisFemaleRadiologyTomography X-Ray ComputedbusinessVaricesDilatation PathologicFollow-Up Studies
researchProduct

Emotional eating as a mediator between anxiety and cholesterol in population with overweight and hypertension

2016

Although the relationship between cholesterol and mood states (especially anxiety) has been well studied, few researches have included the role of eating styles in this relationship. This study explored the associations among eating styles, negative emotional symptoms, and levels of cholesterol (and other medical variables) in a population with hypertension and overweight or obesity, analyzing the possible mediation mechanisms involved. A cross-sectional study was conducted in 68 adults with hypertension and overweight/obesity, and stepwise multiple regression analysis and mediation analyses were carried out to test the hypothesis that eating styles mediate the relationship between negative…

AdultMale0301 basic medicineMediation (statistics)medicine.medical_specialtyHypercholesterolemiaStatistics as TopicPopulation030204 cardiovascular system & hematologyOverweightHigh cholesterol03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesmedicineHumansAffective SymptomsPsychiatryeducationApplied PsychologyAgededucation.field_of_study030109 nutrition & dieteticsFeeding BehaviorMiddle AgedOverweightEmotional eatingmedicine.diseaseAnxiety DisordersObesityPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesMoodHypertensionAnxietyFemalelipids (amino acids peptides and proteins)medicine.symptomPsychologyClinical psychologyPsychology, Health & Medicine
researchProduct

Epicardial Adipose Tissue Accumulation and Essential Hypertension in Non-Obese Adults

2019

Background and Objectives: Epicardial adipose tissue (EAT) is shown to be an important factor in the development of coronary artery disease, but numerous pathophysiological mechanisms of its action are still only partially understood. There is a lack of studies on its association with different grades of essential hypertension (EH). Therefore, we aimed to evaluate the association between size of EAT depots and the risk of EH taking into account its grade. Materials and Methods: Non-obese adult patients with various cardiovascular diseases were investigated: 157 of them had essential hypertension and 101 did not. Hypertensive patients were assigned to three groups according to the grade of h…

AdultMale0301 basic medicineMedicine (General)medicine.medical_specialtyepicardial fatBlood Pressure030204 cardiovascular system & hematologyEssential hypertensionArticleBody Mass IndexCoronary artery disease03 medical and health sciencesR5-9200302 clinical medicineNon obeseCardiac magnetic resonance imagingInternal medicinegrade of hypertensionmedicineepicardial fat ; primary hypertension ; grade of hypertension ; risk assessment ; adultsadultsHumansAged2. Zero hungermedicine.diagnostic_testAdult patientsbusiness.industryrisk assessmentGeneral MedicineMiddle Agedmedicine.diseasePathophysiology3. Good healthprimary hypertension030104 developmental biologyAdipose TissueEpicardial adipose tissueCardiologyepicardial fat; primary hypertension; grade of hypertension; risk assessment; adultsFemaleEssential HypertensionbusinessPericardiumBody mass indexMedicina
researchProduct

A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer

2021

Aim: To determine a recommended Phase II dose of the oral fluoropyrimidine trifluridine/tipiracil (FTD/TPI) combined with the multi-kinase inhibitor regorafenib (REG) in refractory metastatic colorectal cancer patients. Materials & methods: A conventional 3 + 3 dose finding design was used. FTD/TPI was administered on days 1–5 and 8–12 of a 28-day cycle, REG on days 2–22. Two dose levels were used: FTD/TPI 25 mg/m2 b.i.d. + REG 120 mg/d, then escalated to FTD/TPI 35 mg/m2 b.i.d. + REG 120 mg/d. Results: In total, 12 patients were treated at two dose levels. Three dose-limiting toxicities were observed; all were grade 3 hypertension causally attributed to REG. Recommended Phase II dose …

AdultMale0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyPyrrolidinesMaximum Tolerated DosePyridinesColorectal cancerAdministration OralTrifluridineDrug Administration ScheduleTrifluridine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRefractoryRegorafenibInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineDose escalationHumansResponse Evaluation Criteria in Solid TumorsAgedTipiracilDose-Response Relationship Drugbusiness.industryPhenylurea CompoundsGeneral MedicineMiddle Agedmedicine.diseaseProgression-Free SurvivalDrug Combinations030104 developmental biologyOncologychemistryThird lineDrug Resistance Neoplasm030220 oncology & carcinogenesisHypertensionToxicityFeasibility StudiesFemaleColorectal NeoplasmsbusinessThyminemedicine.drugFuture Oncology
researchProduct

Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects.

2003

Background: There has been an increase in research into the association between angiotensin-converting enzyme (ACE) gene deletion polymorphism and cardiovascular disease, with conflicting results. The present prospective long-term study was conducted to evaluate whether the DD genotype could also be associated with a higher prevalence of hypertension in healthy subjects, over 6 years of follow-up. Methods: Population: 684 healthy volunteers (aged, 25–55 years): normotensive and free of cardiovascular diseases, with acceptable echocardiographic window. All subjects had to have a normal electrocardiogram (ECG) and echocardiogram (ECHO) at entry. Study protocol: All subjects underwent a comple…

AdultMaleACE-I/D gene polymorphismmedicine.medical_specialtyTime FactorsGenotypePopulationBlood PressurePeptidyl-Dipeptidase AReference ValuesInternal medicineMedicineHumansProspective StudiesFamily historyeducationeducation.field_of_studyPolymorphism Geneticbiologybusiness.industryIncidence (epidemiology)IncidenceAngiotensin-converting enzymeVenous bloodMiddle Agedmedicine.diseaseMutagenesis InsertionalEndocrinologyBlood pressureHeart failureHypertensionbiology.proteinFemaleGene polymorphismCardiology and Cardiovascular MedicinebusinessHealthy subjectGene DeletionFollow-Up StudiesEuropean journal of heart failure
researchProduct

Observations of time-based measures of flow-mediated dilation of forearm conduit arteries: implications for the accurate assessment of endothelial fu…

2010

Endothelium-dependent flow-mediated dilation (FMD) is measured as the increase in diameter of a conduit artery in response to reactive hyperemia, assessed either at a fixed time point [usually 60-s post-cuff deflation (FMD60)] or as the maximal dilation during a 5-min continuous, ECG-gated, measurement (FMDmax-cont). Preliminary evidence suggests that the time between reactive hyperemia and peak dilation (time to FMDmax) may provide an additional index of endothelial health. We measured FMDmax-cont, FMD60, and time to FMDmax in 30 young healthy volunteers, 22 healthy middle-aged adults, 16 smokers, 23 patients with hypertension, 40 patients with coronary artery disease, and 22 patients wit…

AdultMaleAdolescentBrachial ArteryEndotheliumPhysiologyCoronary Artery DiseaseElectrical conduitForearmPhysiology (medical)medicineHumanscardiovascular diseasesEnzyme InhibitorsReactive hyperemiaHeart FailureAnalysis of Variancebusiness.industrySmokingMiddle AgedVasodilationNG-Nitroarginine Methyl Estermedicine.anatomical_structureRegional Blood FlowAnesthesiaHypertensionCirculatory systemcardiovascular systemDilation (morphology)FemaleEndothelium VascularCardiology and Cardiovascular MedicinebusinessBlood vesselArteryAmerican Journal of Physiology-Heart and Circulatory Physiology
researchProduct

Cardiac involvement in Friedreich's ataxia: our experience.

2009

AdultMaleAdolescentIncidenceFriedreich's ataxiaMiddle AgedAntioxidantsSampling StudiesFriedreich AtaxiaPrevalenceHumansFemaleHypertrophy Left VentricularSicilyAntihypertensive AgentsFollow-Up StudiesRetrospective Studies
researchProduct